Effects of Reducing Norepinephrine Levels via DSP4 Treatment on Amyloid-β Pathology in Female Rhesus Macaques (Macaca Mulatta)
Kara B. Duffy(University of Maryland, College Park), Julie A. Mattison(National Institute on Aging), Richard Herbert(National Institutes of Health), Donald K. Ingram(Pennington Biomedical Research Center), Gregory P. Tinkler(Kent State University), Nigel H. Greig(National Institutes of Health), Debomoy K. Lahiri(Indiana University – Purdue University Indianapolis), Edward M. Tilmont(National Institute on Aging), Balmiki Ray(Indiana University School of Medicine), Mary Ann Ottinger(University of Houston)
Cited by 16
Related Papers
Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease
|Nature Neuroscience|2019|1.7k
Adverse Outcome Pathway (AOP) Development I: Strategies and Principles
|Toxicological Sciences|2014|725
Interventions to Slow Aging in Humans: Are We Ready?
|Aging Cell|2015|598
Aging in Rhesus Monkeys: Relevance to Human Health Interventions
|Science|2004|363
GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease
|Journal of Alzheimer s Disease|2010|325